The global blood gas and electrolyte analyzer market size is expected to reach USD 2.59 billion by 2030, registering a CAGR of 5.5%, according to a new study by Grand View Research Inc. Rising number of patients in ICU and critical care units and increasing demand for high throughput and integrated systems are some key factors likely to drive the blood gas and electrolyte analyzers market. Growing global geriatric population base is also expected to significantly contribute towards market growth over the forecast period, by triggering the incidence rates of target diseases and widening the base of patients requiring critical care. Furthermore, the emergence of multi-parameter monitoring devices owing to, expanding test menus and growing demand for portable devices is expected to boost usage rates over the forecast period. The availability of blood gas analyzers has helped enhance the care of critically ill patients allowing for frequent diagnosis and monitoring of respiratory problems and ability to guide prognosis and therapy. Rising demand for technically advanced sleek handheld devices involving short turnaround time has resulted in the development of more compact, sleek, handheld point-of-care devices. For instance, the OPTI CCA-TS2 blood gas and electrolyte analyzers use innovative optical technology and provide fast results while requiring minimal maintenance.
Request a free sample copy or view report summary: Blood Gas And Electrolyte Analyzer Market Report
Portable analyzers dominated the market with a share of over 62.3% in 2022 and are also expected to witness lucrative growth over the forecast period. Growing demand for automated, self-monitoring, portable devices, shorter analysis time, and quick accurate results are key factors boosting the growth of this segment.
Combined blood gas and electrolyte analyzers are expected to rapidly gain market share over the forecast period. Rising need for analyzers, which can analyze blood and electrolyte samples together are swiftly gaining popularity among users.
North America accounted for more than 40.0% of the blood gas and electrolyte analyzers market in 2014. Presence of sophisticated healthcare infrastructure along with favorable reimbursement plans are some key factors expected to drive regional market growth.
Presence of high unmet needs clubbed with rapidly improving healthcare infrastructure in the emerging markets of India and China is expected to help Asia Pacific grow at a lucrative rate throughout the forecast period. Growing demand for decentralized point-of-care diagnostic facilities handling large volumes of diagnostic tests is also expected to drive regional market growth.
Grand View Research has segmented the global blood gas and electrolyte analyzer market on the basis of product, application, end-use, and region:
Blood Gas And Electrolyte Analyzer Product Outlook (Revenue, USD Million, 2018 - 2030)
Benchtop
Portable
Blood Gas And Electrolyte Analyzer Application Outlook (Revenue, USD Million, 2018 - 2030)
Blood Gas Analyzers
Electrolyte Analyzers
Combined Analyzers
Blood Gas And Electrolyte Analyzer End-use Outlook (Revenue, USD Million, 2018 - 2030)
Clinical Laboratories
Point-of-Care
Blood Gas And Electrolyte Analyzer Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
China
Japan
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Saudi Arabia
South Africa
UAE
Kuwait
List of Key Players in Blood Gas And Electrolyte Analyzer Market
Abbott Point of Care Inc.
Cornley Hi-tech Co., LTD
Radiometer Medical ApS
EDAN Instruments, Inc.
ERBA Diagnostics Mannheim GmbH
F Hoffman La Roche Ltd.
Fortress Diagnostics
Instrumentation Laboratories
LifeHealth
Medica Corporation
Nova Biomedical Corporation
OPTI Medical Systems, Inc.
Sensa Core
Siemens Medical Solutions USA, Inc.
"The quality of research they have done for us has been excellent..."